[{"Assets_0_Q2_USD":6195300000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":145865570.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":146068025.0,"EarningsPerShareBasic_2_Q2_USD":0.18,"EarningsPerShareBasic_1_Q2_USD":0.23,"StockholdersEquityConverted_0_Q2_USD":1716100000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":147769691.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":147690921.0,"StockholdersEquity_0_Q2_USD":1716100000.0,"RevenuesConverted_2_Q2_USD":1386100000.0,"RevenuesConverted_1_Q2_USD":721400000.0,"NetIncomeLossConverted_2_Q2_USD":45600000.0,"NetIncomeLossConverted_1_Q2_USD":45500000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":145900000.0,"CommonStockSharesOutstanding_0_Q2_shares":146359453.0,"CommonStockSharesConverted_0_Q2_shares":146359453.0,"EarningsPerShareDiluted_1_Q2_USD":0.23,"EarningsPerShareDiluted_2_Q2_USD":0.18,"Ticker":"CTLT","CIK":"1596783","name":"CATALENT, INC.","OfficialName":"Catalent Inc. Common Stock","form":"10-Q","period":"20191231","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"17076283108.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20200203"}]